Abstract Search

ea0070oc3.5 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Supplementation with Bifidobacterium breve BR03 and Bifidobacterium breve B632 favoured weight loss and improved insulin metabolism in children and adolescents with obesity in the BIFI-OBESE cross-over, randomized placebo-controlled trial

Solito Arianna , Hasballa Iderina , Calgaro Matteo , Bozzi Cionci Nicole , Ricotti Roberta , Caputo Marina , Genoni Giulia , Monzani Alice , Archero Francesca , Bellone Simonetta , Bona Gianni , Agosti Emanuela , Aimaretti Gianluca , Amoruso Angela , Pane Marco , Vitulo Nicola , Di Gioia Diana , Prodam Flavia

Background: Variations in gut microbiota might impact metabolic functions like caloric intake and energy expenditure leading to body weight excess. Microbiota modulation may be a potential approach for obesity management, especially in subject characterized by specific microbial enterotypes.Objective: We aimed to assess the impact of probiotic treatment in obese children and adolescents, under diet control, on weight loss, glucose, and insulin homeostasi...

0 shares

Endocrine Abstracts

Supplementation with Bifidobacterium breve BR03 and Bifidobacterium breve B632 favoured weight loss and improved insulin metabolism in children and adolescents with obesity in the BIFI-OBESE cross-over, randomized placebo-controlled trial

BiosciAbstracts